326 related articles for article (PubMed ID: 28882452)
41. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
[TBL] [Abstract][Full Text] [Related]
42. Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome.
Reynaud-Dulaurier R; Benegiamo G; Marrocco E; Al-Tannir R; Surace EM; Auwerx J; Decressac M
Brain; 2020 Jun; 143(6):1686-1696. PubMed ID: 32413099
[TBL] [Abstract][Full Text] [Related]
43. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice.
Wu J; Solanes P; Nist-Lund C; Spataro S; Shubina-Oleinik O; Marcovich I; Goldberg H; Schneider BL; Holt JR
Mol Ther; 2021 Mar; 29(3):973-988. PubMed ID: 33212302
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
45. The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
Migdalska-Richards A; Wegrzynowicz M; Rusconi R; Deangeli G; Di Monte DA; Spillantini MG; Schapira AHV
Brain; 2017 Oct; 140(10):2706-2721. PubMed ID: 28969384
[TBL] [Abstract][Full Text] [Related]
46. Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector.
Van der Perren A; Casteels C; Van Laere K; Gijsbers R; Van den Haute C; Baekelandt V
J Vis Exp; 2016 Feb; (108):53670. PubMed ID: 26967677
[TBL] [Abstract][Full Text] [Related]
47. Optimization of Dexamethasone Administration for Maintaining Global Transduction Efficacy of Adeno-Associated Virus Serotype 9.
Chai Z; Zhang X; Dobbins AL; Rigsbee KM; Wang B; Samulski RJ; Li C
Hum Gene Ther; 2019 Jul; 30(7):829-840. PubMed ID: 30700148
[TBL] [Abstract][Full Text] [Related]
48. Intravenous Infusion of AAV for Widespread Gene Delivery to the Nervous System.
Gessler DJ; Tai PWL; Li J; Gao G
Methods Mol Biol; 2019; 1950():143-163. PubMed ID: 30783972
[TBL] [Abstract][Full Text] [Related]
49. Intraarticular Adeno-Associated Virus Serotype AAV-PHP.S-Mediated Chemogenetic Targeting of Knee-Innervating Dorsal Root Ganglion Neurons Alleviates Inflammatory Pain in Mice.
Chakrabarti S; Pattison LA; Doleschall B; Rickman RH; Blake H; Callejo G; Heppenstall PA; Smith ESJ
Arthritis Rheumatol; 2020 Oct; 72(10):1749-1758. PubMed ID: 32418284
[TBL] [Abstract][Full Text] [Related]
50. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
[TBL] [Abstract][Full Text] [Related]
51. AAV Vectors for Efficient Gene Delivery to Rodent Hearts.
Lopez-Gordo E; Kohlbrenner E; Katz MG; Weber T
Methods Mol Biol; 2019; 1950():311-332. PubMed ID: 30783983
[TBL] [Abstract][Full Text] [Related]
52. Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B.
Jackson KL; Dayton RD; Deverman BE; Klein RL
Front Mol Neurosci; 2016; 9():116. PubMed ID: 27867348
[TBL] [Abstract][Full Text] [Related]
53. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
54. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates.
Gray SJ; Nagabhushan Kalburgi S; McCown TJ; Jude Samulski R
Gene Ther; 2013 Apr; 20(4):450-9. PubMed ID: 23303281
[TBL] [Abstract][Full Text] [Related]
55. Systemic Delivery of Genes to Retina Using Adeno-Associated Viruses.
Simpson CP; Bolch SN; Zhu P; Weidert F; Dinculescu A; Lobanova ES
Adv Exp Med Biol; 2019; 1185():109-112. PubMed ID: 31884597
[TBL] [Abstract][Full Text] [Related]
56. Gene transfer to the CNS using recombinant adeno-associated virus.
Stoica L; Ahmed SS; Gao G; Sena-Esteves M
Curr Protoc Microbiol; 2013; Chapter 14():14D.5.1-14D.5.18. PubMed ID: 23686825
[TBL] [Abstract][Full Text] [Related]
57. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
58. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
[TBL] [Abstract][Full Text] [Related]
59. A Single Vector Platform for High-Level Gene Transduction of Central Neurons: Adeno-Associated Virus Vector Equipped with the Tet-Off System.
Sohn J; Takahashi M; Okamoto S; Ishida Y; Furuta T; Hioki H
PLoS One; 2017; 12(1):e0169611. PubMed ID: 28060929
[TBL] [Abstract][Full Text] [Related]
60. Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters.
Husain T; Passini MA; Parente MK; Fraser NW; Wolfe JH
Gene Ther; 2009 Jul; 16(7):927-32. PubMed ID: 19458648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
